Arrowhead stock gains on trial data for Alzheimer’s drug (ARWR)
Arrowhead stock gains on trial data for Alzheimer’s drug (ARWR) Seeking Alpha
Covered in this story
Call it yourself
No calls on $ARWR yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Arrowhead Pharmaceuticals Inc →Summary aggregated from Seeking Alpha's public RSS feed. The full reporting belongs to Seeking Alpha — please read it on their site.